Evaluating diagnostic tests during outbreaks: challenges and lessons learnt from COVID-19
BMJ Glob Health
.
2023 Jul;8(7):e012506.
doi: 10.1136/bmjgh-2023-012506.
Authors
Camille Escadafal
1
,
Rossella Baldan
2
,
Margaretha De Vos
3
,
Ryan Jose Ruiz
2
,
Devy M Emperador
4
,
Alltalents T Murahwa
4
,
Aurélien Macé
5
,
Daniel G Bausch
6
,
Aurélia Vessière
4
,
Jilian A Sacks
4
Affiliations
1
Pandemic Threats programme, FIND, Geneva, Switzerland camille.escadafal@finddx.org.
2
Clinical trial unit, FIND, Geneva, Switzerland.
3
Tuberculosis programme, FIND, Geneva, Switzerland.
4
Pandemic Threats programme, FIND, Geneva, Switzerland.
5
Data science unit, FIND, Geneva, Switzerland.
6
Global Health Security programme, FIND, Geneva, Switzerland.
PMID:
37429698
PMCID:
PMC10335566
DOI:
10.1136/bmjgh-2023-012506
No abstract available
Keywords:
COVID-19; Clinical trial; Diagnostics and tools.
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Testing
COVID-19*
Diagnostic Tests, Routine
Disease Outbreaks / prevention & control
Humans